Find The Best No.1 Interview Magazine Brand Of Odisha

India’s first intranasal vaccine for Covid gets DCGI approval

by Dikhyaa Mohanty
8 views
0
(0)

India’s first intranasal Covid vaccine by Bharat Biotech got approval from the Drug Controller General of India for the 18+ age group for restricted use in emergency situations.

According to the reports, Union Health Minister Mansukh Mandaviya termed it a ‘big boost to India’s fight against Covid-19. “Big Boost to India’s Fight Against COVID-19! Bharat Biotech’s ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in the 18+ age group for restricted use in an emergency situation,” Mandaviya tweeted.

In the subsequent tweet, he said, “This step will further strengthen our collective fight against the pandemic. India has harnessed its science, R&D, and human resources in the fight against COVID-19 under PM @NarendraModi Ji’s leadership. With the science-driven approach & Sabka Prayas, we will defeat COVID-19”, he said.

Do you find this post useful?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

You may also like

Leave a Comment